ZyVersa Therapeutics Statistics
Total Valuation
ZVSA has a market cap or net worth of $1.95 million. The enterprise value is $422,858.
Important Dates
The last earnings date was Monday, May 12, 2025, before market open.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVSA has 3.62 million shares outstanding. The number of shares has increased by 1,038.50% in one year.
| Current Share Class | 3.62M |
| Shares Outstanding | 3.62M |
| Shares Change (YoY) | +1,038.50% |
| Shares Change (QoQ) | +101.47% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 2.70% |
| Float | 3.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.16 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.15
| Current Ratio | 0.15 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -33.86 |
Financial Efficiency
Return on equity (ROE) is -96.10% and return on invested capital (ROIC) is -58.27%.
| Return on Equity (ROE) | -96.10% |
| Return on Assets (ROA) | -26.74% |
| Return on Invested Capital (ROIC) | -58.27% |
| Return on Capital Employed (ROCE) | -97.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.34M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ZVSA has paid $6,745 in taxes.
| Income Tax | 6,745 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.95% in the last 52 weeks. The beta is 0.66, so ZVSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | -89.95% |
| 50-Day Moving Average | 0.74 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 40.61 |
| Average Volume (20 Days) | 4,315,793 |
Short Selling Information
The latest short interest is 362,267, so 10.01% of the outstanding shares have been sold short.
| Short Interest | 362,267 |
| Short Previous Month | 509,086 |
| Short % of Shares Out | 10.01% |
| Short % of Float | 10.03% |
| Short Ratio (days to cover) | 0.09 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -9.14M |
| Pretax Income | -22.42M |
| Net Income | -9.41M |
| EBITDA | -9.13M |
| EBIT | -9.14M |
| Earnings Per Share (EPS) | -$8.48 |
Full Income StatementBalance Sheet
The company has $1.53 million in cash and n/a in debt, giving a net cash position of $1.53 million or $0.42 per share.
| Cash & Cash Equivalents | 1.53M |
| Total Debt | n/a |
| Net Cash | 1.53M |
| Net Cash Per Share | $0.42 |
| Equity (Book Value) | 8.52M |
| Book Value Per Share | 3.40 |
| Working Capital | -9.52M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |